30 TECHNOLOGY: UNLOCKING AND DELIVERING THE POTENTIAL OF THERAPEUTIC NITRIC OXIDE

£5mn funding to develop new treatments for multi-drug resistant tuberculosis

Phase II clinical trial approved for the treatment of chronic infection in patients with cystic fibrosis

NEW MULTICENTRE CLINICAL TRIAL APPROVED TO PREVENT TRANSMISSION OF COVID-19

Scroll Down

30 TECHNOLOGY is developing and defining new models of care by unlocking the potential of Nitric Oxide to treat a host of serious medical conditions.

30 TECHNOLOGY Therapeutic Nitric Oxide